These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 36549605)
1. Amyloid Deposition and Dendritic Complexity of Corticocortical Projection Cells in Five Familial Alzheimer's Disease Mouse. Plachez C; Tsytsarev V; Zhao S; Erzurumlu RS Neuroscience; 2023 Feb; 512():85-98. PubMed ID: 36549605 [TBL] [Abstract][Full Text] [Related]
2. Disrupted Maturation of Prefrontal Layer 5 Neuronal Circuits in an Alzheimer's Mouse Model of Amyloid Deposition. Chen C; Wei J; Ma X; Xia B; Shakir N; Zhang JK; Zhang L; Cui Y; Ferguson D; Qiu S; Bai F Neurosci Bull; 2023 Jun; 39(6):881-892. PubMed ID: 36152121 [TBL] [Abstract][Full Text] [Related]
3. Parvalbumin-Positive Neuron Loss and Amyloid-β Deposits in the Frontal Cortex of Alzheimer's Disease-Related Mice. Ali F; Baringer SL; Neal A; Choi EY; Kwan AC J Alzheimers Dis; 2019; 72(4):1323-1339. PubMed ID: 31743995 [TBL] [Abstract][Full Text] [Related]
4. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease. Kuznetsova E; Schliebs R Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514 [TBL] [Abstract][Full Text] [Related]
5. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. Oakley H; Cole SL; Logan S; Maus E; Shao P; Craft J; Guillozet-Bongaarts A; Ohno M; Disterhoft J; Van Eldik L; Berry R; Vassar R J Neurosci; 2006 Oct; 26(40):10129-40. PubMed ID: 17021169 [TBL] [Abstract][Full Text] [Related]
6. Area-specific alterations of synaptic plasticity in the 5XFAD mouse model of Alzheimer's disease: dissociation between somatosensory cortex and hippocampus. Crouzin N; Baranger K; Cavalier M; Marchalant Y; Cohen-Solal C; Roman FS; Khrestchatisky M; Rivera S; Féron F; Vignes M PLoS One; 2013; 8(9):e74667. PubMed ID: 24069328 [TBL] [Abstract][Full Text] [Related]
7. Correlation between orphan nuclear receptor Nurr1 expression and amyloid deposition in 5XFAD mice, an animal model of Alzheimer's disease. Moon M; Jeong I; Kim CH; Kim J; Lee PK; Mook-Jung I; Leblanc P; Kim KS J Neurochem; 2015 Jan; 132(2):254-62. PubMed ID: 25156412 [TBL] [Abstract][Full Text] [Related]
10. Preservation of dendritic spine morphology and postsynaptic signaling markers after treatment with solid lipid curcumin particles in the 5xFAD mouse model of Alzheimer's amyloidosis. Maiti P; Bowers Z; Bourcier-Schultz A; Morse J; Dunbar GL Alzheimers Res Ther; 2021 Feb; 13(1):37. PubMed ID: 33557949 [TBL] [Abstract][Full Text] [Related]
11. Amyloid plaque-independent deficit of early postnatal visual cortical plasticity in the 5XFAD transgenic model of Alzheimer's disease. Maya-Vetencourt JF; Carucci NM; Capsoni S; Cattaneo A J Alzheimers Dis; 2014; 42(1):103-7. PubMed ID: 24844685 [TBL] [Abstract][Full Text] [Related]
12. Solid lipid curcumin particles provide greater anti-amyloid, anti-inflammatory and neuroprotective effects than curcumin in the 5xFAD mouse model of Alzheimer's disease. Maiti P; Paladugu L; Dunbar GL BMC Neurosci; 2018 Feb; 19(1):7. PubMed ID: 29471781 [TBL] [Abstract][Full Text] [Related]
13. Early-onset formation of parenchymal plaque amyloid abrogates cerebral microvascular amyloid accumulation in transgenic mice. Xu F; Kotarba AE; Ou-Yang MH; Fu Z; Davis J; Smith SO; Van Nostrand WE J Biol Chem; 2014 Jun; 289(25):17895-908. PubMed ID: 24828504 [TBL] [Abstract][Full Text] [Related]
14. Genetic reductions of beta-site amyloid precursor protein-cleaving enzyme 1 and amyloid-beta ameliorate impairment of conditioned taste aversion memory in 5XFAD Alzheimer's disease model mice. Devi L; Ohno M Eur J Neurosci; 2010 Jan; 31(1):110-8. PubMed ID: 20092558 [TBL] [Abstract][Full Text] [Related]
15. Most dystrophic neurites in the common 5xFAD Alzheimer mouse model originate from axon terminals. Mabrouk R; Miettinen PO; Tanila H Neurobiol Dis; 2023 Jun; 182():106150. PubMed ID: 37172911 [TBL] [Abstract][Full Text] [Related]
16. Early detection of cerebral glucose uptake changes in the 5XFAD mouse. Macdonald IR; DeBay DR; Reid GA; O'Leary TP; Jollymore CT; Mawko G; Burrell S; Martin E; Bowen CV; Brown RE; Darvesh S Curr Alzheimer Res; 2014; 11(5):450-60. PubMed ID: 24801216 [TBL] [Abstract][Full Text] [Related]
17. Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Aβ aggregation in the 5XFAD mouse model of Alzheimer's disease. Jawhar S; Trawicka A; Jenneckens C; Bayer TA; Wirths O Neurobiol Aging; 2012 Jan; 33(1):196.e29-40. PubMed ID: 20619937 [TBL] [Abstract][Full Text] [Related]
19. Distinct and Convergent Alterations of Entorhinal Cortical Circuits in Two Mouse Models for Alzheimer's Disease and Related Disorders. Zhong P; Cao Q; Yan Z J Alzheimers Dis; 2024; 98(3):1121-1131. PubMed ID: 38489190 [TBL] [Abstract][Full Text] [Related]
20. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models. Liao F; Zhang TJ; Jiang H; Lefton KB; Robinson GO; Vassar R; Sullivan PM; Holtzman DM Acta Neuropathol Commun; 2015 Nov; 3():70. PubMed ID: 26556230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]